MEGIN
  • About us
  • MEG Maps™
    • What is MEG Maps™
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts & Studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
    • MEGIN Community
  • 🇨🇳
Select Page
MEGIN Matters May 2025

MEGIN Matters May 2025

by Naomi Devlin | May 30, 2025 | MEGIN Matters

An adversarial collaboration for testing theories of consciousness

An adversarial collaboration for testing theories of consciousness

by Naomi Devlin | May 9, 2025 | Masterclass - Basic Research

MEGIN Matters – April 2025

MEGIN Matters – April 2025

by Naomi Devlin | Apr 23, 2025 | MEGIN Matters

Accurate yet MRI-free magnetic source imaging with the pseudo-MRI engine

Accurate yet MRI-free magnetic source imaging with the pseudo-MRI engine

by Naomi Devlin | Apr 8, 2025 | Masterclass - Data Acquisition and Analysis

Professor Debopam Samanta and Assistant Professor Diana Escalona-Vargas from Arkansas Children’s Hospital

Professor Debopam Samanta and Assistant Professor Diana Escalona-Vargas from Arkansas Children’s Hospital

by Naomi Devlin | Mar 24, 2025 | Spotlights - Clinical MEG

MEGIN Spotlights MEGIN Spotlight – Arkansas Children’s Hospital As Medical and Scientific Directors of the hospital’s MEG lab, our guests, Professor Debopam Samanta and Assistant Professor Diana Escalona-Vargas, discuss the role of MEG in pediatric epilepsy...
« Older Entries

Subscribe to MEGIN Matters

Don't miss the latest MEG insights and MEGIN news - complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!

Join Our Mailing List

Home
About us

MEG Maps™
Careers
Contact us
Join Our Mailing List

Insights & education
News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

MEGIN Community

Patients

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2025© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.

Subscribe to MEGIN Matters

Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!